Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy

BACKGROUND: Up to 80% of breast cancer patients suffer from Cancer Related Cognitive Impairments (CRCI). Exercise is suggested as a potential supportive care option to reduce cognitive decline in cancer patients. This study will investigate the effects of a high-intensity interval endurance training...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberste, Max, Schaffrath, Nils, Schmidt, Katharina, Bloch, Wilhelm, Jäger, Elke, Steindorf, Karen, Hartig, Philipp, Joisten, Niklas, Zimmer, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220507/
https://www.ncbi.nlm.nih.gov/pubmed/30400840
http://dx.doi.org/10.1186/s12885-018-4992-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220507/
https://www.ncbi.nlm.nih.gov/pubmed/30400840
http://dx.doi.org/10.1186/s12885-018-4992-3

Ejemplares similares